ZentekZTEK
About: Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.
Employees: 25
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
167% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 3
29% more funds holding
Funds holding: 17 [Q4 2024] → 22 (+5) [Q1 2025]
9% more capital invested
Capital invested by funds: $1.6M [Q4 2024] → $1.74M (+$144K) [Q1 2025]
0.15% less ownership
Funds ownership: 1.64% [Q4 2024] → 1.49% (-0.15%) [Q1 2025]
83% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 6
Research analyst outlook
We haven’t received any recent analyst ratings for ZTEK.
Financial journalist opinion









